<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-ONC-16009596</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2016-10-25</date_registration>
      <primary_sponsor>Xinhua Hospital, Shanghai Jiaotong University School of Medicine</primary_sponsor>
      <public_title>A clinical study of mesenchymal stem cell intravenous infusion for severe genodermatosis</public_title>
      <acronym />
      <scientific_title>A clinical study of mesenchymal stem cell intravenous infusion for severe genodermatosis</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2016-11-01</date_enrolment>
      <type_enrolment />
      <target_size>treatment group:10;</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=16014</url>
      <study_type>Observational study</study_type>
      <study_design>Case series</study_design>
      <phase>New Treatment Measure Clinical Study</phase>
      <hc_freetext>Netherton syndrome</hc_freetext>
      <i_freetext>treatment group:mesenchymal stem cell intravenous infusion ;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Liang Jianying</firstname>
        <middlename />
        <lastname />
        <address>1665 Kongjiang Road, Shanghai, China</address>
        <city />
        <country1 />
        <zip>200092</zip>
        <telephone>+86 13764609948</telephone>
        <email>jianyingliang@163.com</email>
        <affiliation>Xinhua Hospital, Shanghai Jiaotong University School of Medicine</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Yao Zhirong</firstname>
        <middlename />
        <lastname />
        <address>1665 Kongjiang Road, Shanghai, China</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 13601832440</telephone>
        <email>dermatology.yao@sohu.com</email>
        <affiliation>Xinhua Hospital, Shanghai Jiaotong University School of Medicine</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1) diagnosed by clinical manifestation,pathology, spink5 gene sequencing,the expression of LEKTI in skin declined or absent;
2) Male and female aged 1 to 17 years;
3) stable life signs;
4) inform consent form.</inclusion_criteria>
      <agemin>1</agemin>
      <agemax>17</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1) recieved MSCs therapy in 90 days;
2) recieved immunosupressive therapy in 60 days;
3) allergic to any components of UC-MSCs;
4) allergic to penicillin;
5) history fo branchial asthma;
6) acute infection;
7) chronic infection of HIV, HBV, HCV;
8) poor compliance.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>expression of LEKTI protein in skin;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>expressioin of LEKTI protein in serum;</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>require for raise</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2016-09-28</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>